BridgeMD
New treatment option for Brain Tumors
Official title rTMS for Postoperative Brain Tumor Patients
ClinicalTrials.gov ID: NCT07530536
What this study is testing
- What it's testing
- When doctors perform surgery to remove brain tumors, the goal is to take out as much of the tumor as possible while keeping the patient's brain functions intact. However, sometimes patients have trouble with movements like walking or using their hands after surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 to 65
You may be able to join if
- Patients aged 22-65 years old who have undergone surgical resection for a brain tumor.
- Patients undergoing any form of prior therapy, other than previous TMS therapy, will be considered.
- Patients who present with sustained postoperative motor deficits at 1-2 weeks postoperatively as defined by the presence of British Medical Research...
- Patients who present within three years of surgery with chronic, persistent motor-functional deficits will be included to demonstrate...
- Ability to understand and the willingness to sign a written informed consent document.
You likely can't join if
- Patients with any clinical history of seizures.
- Patients with implanted devices (e.g., pacemakers, implanted stimulators, intracranial electrodes, cochlear implants).
- Patients who have undergone a brain biopsy alone without resection.
- Patients with postoperative cognitive deficits as defined by a Mini Mental State Examination score \<26.
- History of bipolar disorder.
- Pregnant or breast-feeding individuals.
See the full eligibility criteria
- Patients aged 22-65 years old who have undergone surgical resection for a brain tumor.
- Patients undergoing any form of prior therapy, other than previous TMS therapy, will be considered.
- Patients who present with sustained postoperative motor deficits at 1-2 weeks postoperatively as defined by the presence of British Medical Research Council (MRC) motor scores of 3/5 or less, or a sustained decrement by...
- Patients who present within three years of surgery with chronic, persistent motor-functional deficits will be included to demonstrate generalizability of safety and how well it works in neurosurgery patients with...
- Ability to understand and the willingness to sign a written informed consent document.
- Patients with any clinical history of seizures.
- Patients with implanted devices (e.g., pacemakers, implanted stimulators, intracranial electrodes, cochlear implants).
- Patients who have undergone a brain biopsy alone without resection.
- Patients with postoperative cognitive deficits as defined by a Mini Mental State Examination score \<26.
- History of bipolar disorder.
- Pregnant or breast-feeding individuals.
- Active suicidal ideation or plan as assessed by the Columbia Suicide Severity Rating Scale.
- History of moderate to severe heart disease.
- History of other neurological conditions defined by structural cerebral damage (e.g., stroke, multiple sclerosis, other neurodegenerative diseases, meningoencephalitis)
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.